These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1318 related items for PubMed ID: 23676191

  • 1. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.
    Geraghty PJ, Mewissen MW, Jaff MR, Ansel GM, VIBRANT Investigators.
    J Vasc Surg; 2013 Aug; 58(2):386-95.e4. PubMed ID: 23676191
    [Abstract] [Full Text] [Related]

  • 2. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K, Gable D, Pearl G, Theune B, Black S.
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T, Peeters P, Bosiers M, Lammer J, Brechtel K, Scheinert D, Rastan A, Noory E, Beschorner U.
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW, Tran K, Itoga N, Casey K, Dalman RL, Lee JT.
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evolving modalities for femoropopliteal interventions.
    Ansel GM, Lumsden AB.
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of covered stent placement for central venous occlusive disease in hemodialysis patients.
    Anaya-Ayala JE, Smolock CJ, Colvard BD, Naoum JJ, Bismuth J, Lumsden AB, Davies MG, Peden EK.
    J Vasc Surg; 2011 Sep; 54(3):754-9. PubMed ID: 21664095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome of thrombolysis and thrombectomy for thrombosed endografts inserted in the superficial femoral artery for occlusive disease.
    Golchehr B, Lensvelt MM, Fritschy WM, Holewijn S, van Walraven LA, van Oostayen JA, Zeebregts CJ, Reijnen MM.
    J Endovasc Ther; 2013 Dec; 20(6):836-43. PubMed ID: 24325702
    [Abstract] [Full Text] [Related]

  • 15. Performance of ePTFE-covered endograft in patients with occlusive disease of the superficial femoral artery: a three-year clinical follow-up study.
    Fritschy WM, Kruse RR, Frakking TG, Van Geloven AA, Blomme AM.
    J Cardiovasc Surg (Torino); 2010 Dec; 51(6):783-90. PubMed ID: 21124274
    [Abstract] [Full Text] [Related]

  • 16. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
    Schneider JR, Verta MJ, Alonzo MJ, Hahn D, Patel NH, Kim S.
    Vasc Endovascular Surg; 2011 Jul; 45(5):391-7. PubMed ID: 21669863
    [Abstract] [Full Text] [Related]

  • 17. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament.
    Calligaro KD, Balraj P, Moudgill N, Rao A, Dougherty MJ, Eisenberg J.
    J Vasc Surg; 2013 Feb; 57(2):421-6. PubMed ID: 23058723
    [Abstract] [Full Text] [Related]

  • 18. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
    Jebran AF, Popov AF, Zenker D, Bireta C, Friedrich M, Danner BC, Bougioukas I, Schoendube FA, Stojanovic T.
    Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
    [Abstract] [Full Text] [Related]

  • 19. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
    Ni Q, Yang S, Xue G, Zhou Z, Zhang L, Ye M.
    Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes of endovascular treatment of TASC-II C and D femoropopliteal lesions with the Viabahn endoprosthesis.
    Mohr PJ, Oyama JK, Luu JT, Stinis CT.
    Cardiovasc Revasc Med; 2015 Dec; 16(8):465-8. PubMed ID: 26483319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.